United Therapeutics Corporation Other Noncash Income
United Therapeutics Corporation (UTHR) reported Other Noncash Income of -$2.11 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-10-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncome · last filed 2011-10-27
- United Therapeutics Corporation other noncash income for the quarter ending 2011-09-30 was $5.83M.
- United Therapeutics Corporation other noncash income for the quarter ending 2011-06-30 was -$1.18M, a 160.56% decline year-over-year.
- United Therapeutics Corporation other noncash income for the quarter ending 2011-03-31 was -$6.77M.
- United Therapeutics Corporation other noncash income for the quarter ending 2010-12-31 was -$419.00K.
- United Therapeutics Corporation other noncash income for fiscal 2010 was -$967.00K, a 152.33% decline from fiscal 2009.
- United Therapeutics Corporation other noncash income for fiscal 2009 was $1.85M, a 26.49% decline from fiscal 2008.
- United Therapeutics Corporation other noncash income for fiscal 2008 was $2.51M.
| Period end | Other Noncash Income 3 month | Other Noncash Income 6 month | Other Noncash Income 9 month | Other Noncash Income 12 month |
|---|---|---|---|---|
| 2011-09-30 | $5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $4.65M derived: sum of 2 quarters · filed 2011-10-27 | -$2.11M 10-Q · filed 2011-10-27 | -$2.53M derived: sum of 4 quarters · filed 2011-10-27 |
| 2011-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$7.94M 10-Q · filed 2011-07-28 | -$8.36M derived: sum of 3 quarters · filed 2011-07-28 | -$8.97M derived: sum of 4 quarters · filed 2011-10-27 |
| 2011-03-31 | -$6.77M 10-Q · filed 2011-04-28 | -$7.19M derived: sum of 2 quarters · filed 2011-04-28 | -$7.79M derived: sum of 3 quarters · filed 2011-10-27 | -$5.85M derived: sum of 4 quarters · filed 2011-10-27 |
| 2010-12-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | -$1.02M derived: sum of 2 quarters · filed 2011-10-27 | $919.00K derived: sum of 3 quarters · filed 2011-10-27 | -$967.00K 10-K · filed 2011-02-24 |
| 2010-09-30 | -$604.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $1.34M derived: sum of 2 quarters · filed 2011-10-27 | -$548.00K 10-Q · filed 2011-10-27 | -$2.19M derived: sum of 4 quarters · filed 2011-10-27 |
| 2010-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $56.00K 10-Q · filed 2011-07-28 | -$1.58M derived: sum of 3 quarters · filed 2011-07-28 | -$1.09M derived: sum of 4 quarters · filed 2011-07-28 |
| 2010-03-31 | -$1.89M 10-Q · filed 2011-04-28 | -$3.53M derived: sum of 2 quarters · filed 2011-04-28 | -$3.04M derived: sum of 3 quarters · filed 2011-04-28 | |
| 2009-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | -$1.15M derived: sum of 2 quarters · filed 2011-02-24 | $1.85M 10-K · filed 2011-02-24 | |
| 2009-09-30 | $490.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $3.49M 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $3.00M 10-Q · filed 2010-07-28 | |||
| 2008-12-31 | $2.51M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |